Abstract: The present invention provides phosphotetrahydropyran compounds and the use thereof in treating diseases or conditions that are dependent on T-lymphocyte migration, as well as compositions containing said compounds.

Abstract: The present invention relates to tetrahydroquinazoline-2,4-diones derivatives of the formula (I): 1

Abstract: The present invention is directed to a compound of the formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, Y, U, W, k, A, E, V, R4 and R5 are as defined herein, pharmaceutical compositions thereof, and methods of use thereof in the inhibition of serotonin reuptake, the inhibition of the binding of 5-HT2A serotonin receptors and the treatment of diseases, conditions or disorders of the central nervous system. Further, the present invention is also directed to methods for the preparation of compounds of formula (I) and intermediates useful therefor.

Abstract: The present invention relates to tetrahydroquinazoline-2,4-diones derivatives of the formula (I): pharmaceutically acceptable salts thereof, wherein A is (CH2)n where n is equal to 0, 1 or 2; U is CH2, NH, or NR3, R1 and R2 are selected independently from H, (C1-C6)alkyl, Cl, F, CN, nitro, CF3, —NHC(O)R6 and —OR7, or R1 and R2, together with the atoms to which they are attached, form a carbocyclic or heterocyclic five- or six-membered ring, R3 is selected from the group consisting of H, (C1-C6)malkyl, C(═O)—(C1-C6)alkyl, where m=1 or 2; R4 and R5 are selected from H, (C1-C6)alkyl, Cl, F, —CF3, —CN, —NHC(═O)R6, —OR7, a 5-to 7-membered aryl or heteroaryl ring, where m, R6 and R7 are as defined above; and R6 and R7 are selected independently from H, (C1-C6)alkyl or a 5- to 7-membered aryl or heteroaryl ring; V is CH, CR3, or N; W is CH2, C(O), or S(O)2; X is C or N; and Y is CH, CR1,CR2, or N.

Abstract: The present invention is directed to a compound of the formula (I): 1

Abstract: The present invention relates to compounds of the formula and the pharmaceutically acceptable salts and solvates thereof wherein X1, X2, X3, R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods of treating shizophrenic and shizo-affective disorders, and related disorders which may be treated by administering compounds having dopaminergic activity such as the above compounds of formula 1.

Abstract: The present invention relates to compounds of the formula 1

Abstract: Therapeutic compositions including a species of Coxiella or one or more antigenic components therefrom or analogous or homologous components thereof are disclosed. These compositions are useful in preventing, inhibiting, delaying onset of or otherwise ameliorating the effects of an autoimmune disease in a mammal, particularly insulin-dependent diabetes mellitus (IDDM). They are also useful in prolonging survival of islet tissue transplanted into a mammal.

Abstract: D-mannoside-6-phosphate compounds having anti-inflammatory activity are disclosed, and use thereof in treating inflammatory diseases, particularly cell-mediated inflammatory diseases.

Abstract: A method for the anticoagulant and/or antithrombotic treatment of a human or other warm-blooded animal patient in need of such treatment, comprises administration to the patient of an effective amount of at least one sulfated oligosaccharide, wherein the oligosaccharide has the general formula I: R1—(Rx)n—R2   (I) wherein R1 and R2 and each Rx represents a monosaccharide unit, all of which may be the same or different, adjacent monosaccharide units being linked by 1→2, 1→3, 1→4 and/or 1→6 glycosidic bonds and n is an integer of from 1 to 6.

Abstract: Sulfated oligosaccharides, wherein the oligosaccharide has the general formula I:R.sub.1 --(R.sub.x).sub.n --R.sub.2 (I)wherein R.sub.1 and R.sub.2 and each R.sub.x represents a monosaccharide unit, all of which may be the same or different, adjacent monosaccharide units being linked by 1.fwdarw.2, 1.fwdarw.3, 1.fwdarw.4 and/or 1.fwdarw.6 glycosidic bonds and n is an integer of from 1 to 6, and use thereof as anti-angiogenic, anti-metastatic and/or anti-inflammatory agents.

Abstract: A method of anti-inflammatory and/or immunosuppressive treatment of a human or otheer warm-blooded animal patient comprises administration to the patient of an effective amount of castanospermine.

Abstract: A method and apparatus for controlling air/fuel ratio of an internal combustion engine at a desired level of richness or leanness utilizes an existing air flow sensor for sensing air flow into the engine and generating a corresponding air flow signal. A signal multiplier multiplies the air flow signal by a constant to generate a modified air flow signal corresponding to the desired level of richness or leanness. A control signal is then generated for controlling the air/fuel ratio to the desired level.

Abstract: A cementitious material in powder form comprising cement, also comprises sufficient of a granulated hydrophobing additive, which comprises from 5 to 15 parts by weight of an organopolysiloxane component, from 10 to 40 parts by weight of a water-soluble or water-dispersible binder and from 50 to 80 parts by weight of a carrier particle, to give from 0.01 to 5% by weight of the organosiloxane component based on the weight of the cement. The cementitious material displays good hydrophobicity, which may improve upon subsequent wettings of the applied cementitious material to a substrate.

Abstract: A curable composition comprises a polysiloxane additive having at least one unit R.sub.a SiO.sub.(4-a)/2 and at least one unit R.sub.b R.sup.1 SiO.sub.(3-b)/2 wherein R is a C.sub.1-12 hydrocarbon, R.sup.1 is --(CH.sub.2).sub.n (OR.sup.2).sub.m X where R.sup.2 is C.sub.2-3 alkylene, a is 0, 1, 2 or 3 and b is 0, 1 or 2, and X is OH or --OCOCR.sup.3 .dbd.CH.sub.2 where R.sup.3 is H, methyl or ethyl, n is 2 to 5 and m is 8 to 50, provided where X is OH, n is 3 and m is 18. The compositions are useful with polyacrylates as overprint varnishes with improved stability of friction coefficients. Also disclosed is a method for making the additives.

Abstract: A method of anti-inflammatory and/or immunosuppressive treatment of a human or otheer warm-blooded animal patient comprises administration to the patient of an effective amount of castanospermine.

Abstract: A three-dimensional apparatus is disclosed that provides a view of the electrical pathway of the heart as it pertains to a corresponding electrocardiogram tracing on an external heart monitoring device. Also provided is a method of simulating propagation of electrical signals in the heart. The heart model interfaces with an arrhythmia generator or electrocardial simulator. The signals generated by the simulator are indicated visually within the heart model through light emitters (such as light emitting diodes, or other light sources) located in such a fashion as to correspond to the electrical pathways found in a living heart. An external monitor, such as an oscilloscope trace unit, also interfaces with the simulator to simultaneously show the electrocardiogram trace that corresponds to the light display in the heart model.

Abstract: The specification discloses a desulfurization process for use in a fossel fuel combustion process involving the generation of a flue gas product containing sulfur oxides and halogen compounds wherein an alkali metal compound is contacted with the gas resulting in the removal of sulfur oxides from the gas and formation of a water-soluble residue comprising alkali metal sulfates and alkali metal halides, which residue is collected from the gas before the gas is released to the environment. The process is adapted to recover the alkali metal ions from the collected residue for use in supplying the alkali metal ions that are contacted with the gas and for limiting the presence co-collected halogen ions within the recovered alkali metal ions. The process comprises dissolving the collected residue in water to form an aqueous solution thereof having a pH of less than about 8 so that sulfate ions, halogen ions and alkali metal ions are present in the solution.

Abstract: Alkali metal sulfates are converted to a sulfur-free form by dissolving the alkali metal sulfate in water to produce an aqueous solution containing alkali metal ions and sulfate ions at a pH below about 8, and then passing the solution through a weak base, anion exchange resin having bicarbonate ions associated therewith that exchange with the sulfate ions so that the sulfate ions become associated with the resin and the bicarbonate ions become associated with the alkali metal ions in the solution. The resin can be regenerated to the bicarbonate form by treatment with an ammonium hydroxide solution followed by contact with carbon dioxide and the regeneration by-products are commercially useful.

Abstract: A one piece resilient fastener is provided for retaining an edge portion of a fabric or other sheet material in clamping engagement between a panel and a trim plate. The invention in its preferred embodiment, is employed in combination with an automobile carpet and serves to retain the carpet in proper location on the automobile floor panel prior to installation of the scuff-plate and to provide a spacer member between the plate and panel after the plate is installed.